Abstract:Cancer immunotherapy aims to reinitiate the autoimmune responses for fighting cancer cells. Immunomodulators, such as immune vaccines, adjuvants, and immune checkpoint inhibitors, have been extensively developed to activate the immune response against cancer. However, it is disadvantageous to directly apply immunomodulators in cancer immunotherapy for the following reasons: (I) instability of immunomodulators; (II) immunomodulators easily cleared; (III) uncontrolled immune response. Many efforts have been made to overcome these drawbacks, among which loading immunomodulators by nanocarriers is a simple and effective method. Nanocarriers can not only protect immunomodulators from degradation but also control their release and extend their blood circulation time. Some nanocarriers can specifically enrich in immune cells or organs to regulate their connection to further modulate the immune system. Besides, response-type nanocarriers can also be designed as required to control the release of immunomodulators to reduce immune-related adverse events. Of note, nanocarriers with excellent photothermal or photodynamic properties play the crucial role in inducing immunogenic cell death for enhanced cancer immunotherapy. In this review, various nanocarriers and their bioapplications in cancer immunotherapy have been summarized. We outlined the inorganic, organic, and organic-inorganic hybrid nanocarriers and the designing of effective nanocarrier-based immune interventions. The prospects and drawbacks of nanocarriers were also further reviewed in this work. This review will provide vital guidance for the design and synthesis of nanocarriers for application in cancer immunotherapy.

Nanocarrier design for pathogen-inspired innate immune agonist delivery

When Natural Compounds Meet Nanotechnology: Nature-Inspired Nanomedicines for Cancer Immunotherapy

Nanoparticles for Immune Stimulation Against Infection, Cancer, and Autoimmunity

Nanocarriers for effective delivery: modulation of innate immunity for the management of infections and the associated complications

Designing and Engineering of Nanocarriers for Bioapplication in Cancer Immunotherapy.

Exploring nanocarriers as innovative materials for advanced drug delivery strategies in onco-immunotherapies

Nano-Delivery of Immunogenic Cell Death Inducers and Immune Checkpoint Blockade Agents: Single-Nanostructure Strategies for Enhancing Immunotherapy

Dual and Multi-Immune Activation Strategies for Emerging Cancer Immunotherapy

Delivery of Therapeutics with Nanoparticles: What's New in Cancer Immunotherapy?

Current Status and Future Directions of Nanoparticulate Strategy for Cancer Immunotherapy

Nanomaterial-based cancer immunotherapy: enhancing treatment strategies

Nanocarrier-based Gene Delivery for Cancer Immunotherapy

Dendritic Nanoparticles for Immune Modulation: A potential next-generation nanocarrier for cancer immunotherapy

Advanced Engineered Nanoparticulate Platforms to Address Key Biological Barriers for Delivering Chemotherapeutic Agents to Target Sites.

Biomimetic nanocarriers: integrating natural functions for advanced therapeutic applications

Pathogen-like Nanoassemblies of Covalently Linked TLR Agonists Enhance CD8 and NK Cell-Mediated Antitumor Immunity

A Nano-Immunotraining Strategy to Enhance the Tumor Targeting of Neutrophils Via in Vivo Pathogen-Mimicking Stimulation

Biomimetic Cell-Derived Nanocarriers for Modulating Immune Responses.

Nanocarrier Co-formulation for Delivery of a TLR7 Agonist plus an Immunogenic Cell Death Stimulus Triggers Effective Pancreatic Cancer Chemo-immunotherapy

Targeted Nanoparticle Drug Delivery System for the Enhancement of Cancer Immunotherapy.

Nanomaterials as Smart Immunomodulator Delivery System for Enhanced Cancer Therapy